APA Citation

Ma, Z., Guo, D., Wang, Q., Liu, P., Xiao, Y., Wu, P., . . . Liu, Q. (2019). Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. Theranostics.

Chicago Style Citation

Ma, Zhili, et al. "Lgr5-mediated P53 Repression Through PDCD5 Leads to Doxorubicin Resistance in Hepatocellular Carcinoma." Theranostics 2019.

MLA Citation

Ma, Zhili, et al. "Lgr5-mediated P53 Repression Through PDCD5 Leads to Doxorubicin Resistance in Hepatocellular Carcinoma." Theranostics 2019.

Warning: These citations may not always be 100% accurate.